查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1961013

血管內超音波市場：市場洞察、競爭格局及至2034年的市場預測

Intravascular Ultrasound Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

血管內超音波市場概述

  • 全球血管內超音波市場規模預計將從 2025 年的 9.2694 億美元成長到 2034 年的 17.7419 億美元，展現出強勁且持續的成長勢頭。
  • 全球血管內超音波市場預計在 2026 年至 2034 年的預測期內將以 7.52% 的複合年成長率成長。
  • 血管內超音波市場的主要驅動力是心血管疾病（CVD）盛行率的不斷上升。人口老化、肥胖、糖尿病和高血壓等風險因素顯著增加了對血管內超音波（IVUS）作為重要診斷和治療工具的需求。隨著全球經皮冠狀動脈介入治療（PCI）數量的增加，IVUS正被廣泛用於提高手術精準度、最佳化支架植入、減少血管再阻塞等併發症。此外，主要市場參與企業正透過策略性收購、夥伴關係和研發投資來加速成長，以開發高解析度成像、3D IVUS和人工智慧驅動的分析等先進的IVUS技術。
  • 血管內超音波市場的主要企業包括 Koninklijke Philips NV、Boston Scientific Corporation、Terumo Corporation、NIPRO、CONAVI MEDICAL、Bracco、Intravascular Imaging Incorporated (i3)、Insight Lifetech Co., Ltd.、上海脈搏醫療科技有限公司、MicroPort Scientific Corporation 有限公司。
  • 由於心血管疾病及其危險因子病例不斷增加，預計北美將引領整個血管內超音波市場的發展。此外，該地區血管成形術數量的增加也進一步推動了血管內超音波市場的擴張。
  • 按類型分類，血管內超音波市場中，預計到 2025 年， IVUS導管類別將佔據最大的市場佔有率。

推動血管內超音波市場成長的因素

  • 心血管疾病及相關風險因素的增加推動了血管內超音波需求的激增：心血管疾病 (CVD) 及高血壓、糖尿病、肥胖等相關風險因素的增加，以及人口老化，正在顯著推動血管內超音波(IVUS) 系統市場的整體成長。
  • 經皮冠狀動脈介入治療（PCI）的快速成長正在推動血管內超音波市場的發展：經經皮冠狀動脈介入治療（PCI）的快速成長正在推動血管內超音波（IVUS）市場的成長，而血管內超音波（IVUS）的日益普及是推動這一成長的主要因素。由於PCI手術具有微創、恢復時間短、手術風險低等治療方法，與傳統的冠狀動脈繞道手術手術（CABG）相比，PCI手術（如血管成形術和支架置入術）已成為冠狀動脈疾病（CAD）的首選治療方法。
  • 主要市場參與企業在收購、合作和研發等策略活動方面激增：在全球範圍內拓展產品開發活動是血管內超音波市場蓬勃發展的基礎。技術進步、疾病適應症的擴展、核准核准和策略合作正在推動創新診斷解決方案的誕生。隨著持續的投資和創新，血管內超音波有望透過為多種疾病提供非侵入性、精準且個人化的診斷工具，從而變革醫療保健產業。

血管內超音波市場報告細分

本血管內超音波市場報告全面概​​述了全球血管內超音波市場，重點分析了關鍵趨勢、成長要素、挑戰和機會。報告按類型（IVUS導管和血管內主機）、應用（冠狀動脈介入治療和周邊血管介入治療）、終端用戶（醫院和診所、診斷影像中心及其他機構）以及地區進行了詳細的市場細分。本報告深入分析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態，並詳細介紹了主要行業參與企業和近期產品創新，為企業提供所需數據，幫助他們識別市場潛力、制定戰略規劃，並在快速成長的血管內超音波市場中把握新機遇。

血管內超音波（IVUS）是一種介入性心臟病學中用於表徵病變形態、量化斑塊負荷、指導支架尺寸、評估支架擴張和識別手術併發症的侵入性、基於導管的成像方式。

血管內超音波市場的主要驅動力是心血管疾病（CVD）盛行率的不斷上升。人口老化、肥胖、糖尿病和高血壓等風險因素顯著增加了對血管內超音波（IVUS）的需求，使其成為重要的診斷和介入工具。隨著全球經皮冠狀動脈介入治療（PCI）數量的不斷增加，IVUS 被廣泛用於提高手術精準度、最佳化支架植入以及減少血管再阻塞等併發症。此外，主要市場參與企業正透過策略性收購、夥伴關係和研發投資來加速成長，以開發高解析度成像、3D IVUS 和人工智慧驅動的分析等先進的 IVUS 技術。

血管內超音波市場的最新市場動態和趨勢是什麼？

近年來，全球血管內超音波市場經歷了顯著成長，這主要是由於心血管疾病 (CVD) 及其相關危險因子的盛行率不斷上升，經經皮冠狀動脈介入治療 (PCI) 的激增帶動了血管內超音波(IVUS) 的日益普及，以及主要市場參與企業產品開發活動的增加。

根據世界心臟聯盟（2024）的數據，心房顫動是最常見的心律不整類型，影響約6,000萬人。心房顫動會增加血栓、心臟衰竭和中風的風險。此外，據同一資訊來源稱，心房顫動患者發生中風的幾率是普通人的五倍。

心房顫動是最常見的心律不整，與血栓性栓塞症、中風和結構性心臟併發症的風險增加有關。隨著肺靜脈阻塞（PVI）、左心耳封堵（LAA）和心房顫動消融術等導管介入治療在心房顫動治療中日益重要，血管內超音波（IVUS）透過提供血管結構的即時高解析度影像，在指導這些手術中發揮關鍵作用，從而推動了整個IVUS市場的發展。

根據英國心臟基金會（2024年）的最新數據，全球約有5,600萬名女性和4,500萬名男性中風倖存者。據估計，全球至少有1,300萬人患有先天性心臟疾病，另有數百萬名患者尚未確診。接受過手術矯正的先天性心臟疾病患者通常需要長期監測和干涉，而血管內超音波（IVUS）作為一種微創診斷工具，可用於評估移植血管的通暢性、評估血管重塑情況以及檢測術後併發症。

此外，根據密西根大學（2024 年）的數據，超過 50 萬美國人接受了經皮冠狀動脈介入治療 (PCI)，這是一種微創手術，用於清除為心臟供血的動脈中的阻塞物。

隨著經皮冠狀動脈介入治療方法（PCI）成為冠狀動脈疾病（CAD）的主要治療方法，介入性心臟科醫師越來越依賴血管內超音波（IVUS）來改善手術效果。與傳統血管造影術不同，IVUS 可提供即時、高解析度的橫斷面影像，從而實現精確的血管評估、斑塊分析和最佳支架置入。這促使 IVUS 的應用日益廣泛，提高了 PCI 的成功率並減少了併發症，進而推動了市場需求。

因此，血管內超音波（IVUS）的發展與每年經皮冠狀動脈介入治療（PCI）手術的數量以及IVUS在支架植入前後應用中的日益普及密切相關。例如，波士頓科學公司提供的OPTICROSS™高清冠狀動脈成像導管可提供高畫質影像，以輔助精準的支架植入和手術效果評估。此外，該公司的AVVIGO™+多重模式引導系統將IVUS與血流儲備分數（FFR）功能相結合，以增強PCI術中的血管成像和生理評估。

此外，產品研發活動的增加也進一步推動了血管內超音波（IVUS）市場的整體發展。例如，2025年3月，波士頓科學公司宣布已簽署最終協議，收購SoniVie有限公司，這是一家開發TIVUS™血管內超音波系統的私人公司。

因此，預計上述因素將在 2020 年至 2034 年的預測期內推動血管內超音波市場的整體發展。

然而，IVUS導管在插入、操作或拔出過程中可能會對動脈壁造成機械性損傷，進而導致血管撕裂。此外，光同調斷層掃瞄（OCT）和先進血管造影術等替代技術的出現，可能會在預測期內限制IVUS的市場發展。

血管內超音波市場細分分析

血管內超音波市場：按類型（IVUS導管和IVUS主機）、按應用（冠狀動脈介入治療和周邊血管介入治療）、按最終用戶（醫院和診所、診斷影像中心、其他）和按地區（北美、歐洲、亞太地區、世界其他地區）分類

血管內超音波市場區域分析

北美血管內超音波市場趨勢

預計到2025年，北美將佔據血管內超音波市場所有地區中最高的佔有率，達到43.72%。這一主導地位主要歸因於心血管疾病及其危險因子病例的不斷增加。此外，全部區域血管成形術數量的成長也進一步推動了血管內超音波市場的擴張。

根據美國疾病管制與預防中心（CDC）發布的最新數據，2022年約有4.8%的成年人被診斷出患有心臟疾病（CHD）。冠心病患者會出現動脈粥狀硬化，導致血流受限，增加心肌梗塞的風險。隨著冠心病病例的增加，對血管內超音波（IVUS）等先進影像診斷技術的需求也隨之成長，從而推動了市場發展。

此外，根據美國疾病管制與預防中心（CDC，2024）的數據，2021年至2023年間，成人肥胖盛行率為40.3%。超重會導致代謝異常，加速斑塊積聚，並增加經皮冠狀動脈介入治療（PCI）的需求。因此，血管經皮超音波（IVUS）在指導支架置入和最佳化治療方面發揮關鍵作用，從而推動了市場成長。

此外，根據密西根大學（2025年）的數據，美國每年進行超過一百萬例血管成形術。在血管成形術中，血管內超音波（IVUS）可以幫助準確評估斑塊和病變特徵，並指導支架的放置和擴張。因此，預計該地區血管內超音波的應用將會成長。

預計這些因素將在預測期內推動美國血管內超音波市場的成長。

歐洲血管內超音波市場趨勢

在歐洲，心血管疾病和糖尿病、肥胖、高血壓等危險因子的日益普遍，推動了全部區域內超音波市場的成長，從而刺激了整個血管內超音波市場的擴張。

根據英國心臟基金會的數據，到 2024 年，將有 760 萬人患有心臟和循環系統疾病。動脈硬化、心肌梗塞和中風等疾病的發病率不斷上升，推動了對血管內超音波(IVUS) 等先進診斷工具的需求，IVUS 可提供冠狀動脈的即時影像，並有助於評估斑塊積聚、血管直徑和支架放置情況。

此外，根據英國糖尿病協會（2024 年）的數據，2023-2024 年英國約有 580 萬人患有糖尿病。

此外，英國政府（2024 年）的數據顯示，18 歲及以上成年人中有 63.8% 超重或肥胖。

此外，根據英國心臟基金會（2025年）的統計數據，英國有500萬成年人患有未確診的高血壓。糖尿病、肥胖和高血壓等危險因子的日益普遍，正推動著血管內超音波（IVUS）引導手術的普及，以期改善手術效果、減少術後併發症並提高患者的長期存活率。

因此，預計上述所有因素將在預測期內推動英國血管內超音波市場的成長。

亞太地區血管內超音波市場趨勢

亞太地區預計在 2026 年至 2034 年的預測期內將以 8.86% 的健康複合年成長率成長，這主要得益於人口老齡化加劇以及心血管疾病和相關風險因素的日益普遍，從而成為血管內超音波市場的主要驅動力。

根據發表在 2024 年美國國家醫學圖書館日誌的一項最新研究，據估計，中國平均約有 3.3 億人患有心血管疾病 (CVD)。

其中，估計有 1,300 萬例中風，1,140 萬例型冠心病，500 萬例肺因性心臟疾病，890 萬例中風，1,140 萬例心臟疾病，500 萬例肺因性心臟病，890 萬例先天性心臟衰竭，490 萬例心臟疾病，250 萬例風濕性心臟病，200 萬例先天性心臟病，4,530 萬例下肢動脈心臟疾病，以及 2.45 億例高血壓。

此外，根據國際糖尿病聯盟糖尿病地圖集（2024 年），預計到 2045 年，中國年齡調整後的相對盛行率（糖尿病）將上升至 12.6%。

由於這些疾病通常伴隨著複雜的動脈阻塞和動脈粥樣硬化，血管內超音波(IVUS) 在提供血管的高解析度即時影像方面發揮著至關重要的作用，使心臟病專家能夠準確評估斑塊負荷、血管大小和病變特徵，從而透過最佳化支架放置和減少血管再阻塞和支架血栓症等併發症來提高經皮冠狀動脈介入治療 (PCI) 的準確性，進而整個血管內生長(IVUS) 推動的準確性，進而整個血管超音波(IVUS)。

血管內超音波市場的主要企業有哪些？

以下列出了血管內超音波市場的主要企業，它們合計佔據最大的市場佔有率，並主導行業趨勢：

  • Koninklijke Philips NV
  • Boston Scientific Corporation
  • Terumo Corporation
  • NIPRO
  • CONAVI MEDICAL
  • Bracco
  • Intravascular Imaging Incorporated (i3)
  • Insight Lifetech Co., Ltd.
  • Shanghai Pulse Medical Technology Inc.
  • MicroPort Scientific Corporation
  • Provisio Medical, Inc.
  • 其他

血管內超音波（IVUS）市場的競爭格局正在發生怎樣的變化？

血管內超音波（IVUS）市場競爭格局高度集中，主要由少數幾家全球醫療技術領導企業主導，包括波士頓科學、飛利浦醫療保健、泰爾茂和美敦力。這些公司憑藉其在導管檢查室的強大影響力、豐富的成像產品組合以及長期以來贏得的臨床醫生信任，佔據了超過一半的市場佔有率。這些公司透過持續的產品創新、人工智慧驅動的成像增強、與介入平台的整合以及策略收購來塑造競爭格​​局，從而提高了新進入者的准入門檻。同時，中小型的利基公司則專注於差異化的導管技術、混合成像或針對特定地區（尤其是新興市場）量身定做的具成本效益解決方案，展開競爭。因此，儘管大型企業保持定價權和規模優勢，但持續的技術進步和對精準引導介入治療的臨床需求，使得市場保持競爭態勢，並未出現完全整合。

血管內超音波市場最新趨勢

  • 2025 年 3 月，波士頓科學公司宣布已簽署最終協議，收購 SoniVie Ltd.，這是一家開發 TIVUS™ 血管內超音波系統的私人公司。
  • 2024 年 10 月，MicroPort Scientific, Inc. 的子公司 MicroPort Microimaging 獲得了國家藥品監督管理局 (NMPA) 對其 Decypher™ IVUS 診斷系統和 Outsight® 一次性 IVUS 診斷導管的上市核准。
  • 2024 年 5 月，Provisio Medical, Inc. 宣布完成了使用 Provisio™ SLT IVUS™ 系統的第一個商業性臨床案例。
  • 2024年4月，Provisio Medical公司的Provisio™ SLT IVUS™系統獲得FDA 510(k)認證，該系統引入了聲波管腔斷層掃描（SLT）技術，無需複雜的影像解讀即可實現即時、自動化的血管管腔測量。它是首個整合血管內成像和支援導管的系統，透過同時提供管腔測量、可視化、導管導引線支撐和造影輸送，增強了血管內手術的效率。
  • 2023 年 10 月，Evident Vascular 結束了隱密模式，獲得了 3,500 萬美元的 A資金籌措，用於開發其血管內成像平台。

影響分析

人工智慧驅動的創新與應用：

人工智慧在血管內超音波（IVUS）領域的創新和應用正在迅速改變血管內超音波的性能和解讀方式，使這項技術從人工圖像閱片發展到自動化、數據驅動的臨床決策支援。最新的人工智慧演算法，特別是深度學習模型，已被開發出來，能夠高精度地自動分割管腔、血管壁、斑塊和支架結構，從而顯著減少IVUS解讀過程中人工標註的需求和操作者之間的差異。這些模型可以輔助對血管成分（例如鈣化和狹窄管腔）進行分類，量化關鍵解剖標誌，並進行病變特徵分析，有助於提高診斷的一致性和治療計劃的發展。人工智慧也被用來預測手術結果（例如旋切動脈粥狀硬化斑塊切除術的影響程度）。透過將IVUS影像與臨床和人口統計資料結合，人工智慧有望應用於更廣泛的不利事件風險預測模型。除了直接的臨床解讀之外，人工智慧也正在加速臨床醫生的培訓和技能提升。例如，我們基於人工智慧的自適應教育平台提供個人化的、基於案例的血管內超音波（IVUS）學習路徑，能夠更有效地培養模式識別和決策能力。這些創新旨在提高工作流程效率，規範影像分析，並擴大血管內超音波在介入心臟病學中的效用和普及程度。

美國關稅對血管內超音波市場的影響分析：

美國對血管內超音波（IVUS）市場徵收關稅的影響，反映了近期旨在將製造業遷回國內、減少對海外供應鏈依賴的關稅政策給整個美國醫療設備行業帶來的更廣泛壓力。根據新的貿易措施，進口醫療設備和組件（包括診斷和影像設備）將被徵收高達兩位數的關稅，這顯著增加了來自中國、歐盟和其他地區的產品的製造和採購成本——而這些地區正是IVUS等先進心血管技術的關鍵供應來源。關稅的提高正在擠壓美國和國際IVUS製造商的利潤空間。製造商被迫將成本轉嫁給醫院和醫療保健機構，或自行承擔更高的投入成本，這可能會在成本敏感的環境下減緩IVUS的普及應用，並推遲成像技術的升級。關稅造成的供應鏈中斷正在降低長期存在的全球生產網路的效率，促使一些公司考慮將生產遷回國內或實現供應來源多元化。然而，由於需要獲得監管部門的核准以及對生產設施進行改造，這些轉型既耗時又昂貴。最終，關稅帶來的成本增加和不確定性可能導致價格上漲，給醫療服務提供者的採購帶來挑戰，並限制對尖端成像技術的需求，從而限制美國血管內超音波（IVUS）市場的成長，除非針對關鍵醫療技術實施政策調整和關稅豁免。

這項分析如何幫助客戶

  • 成本管理：了解關稅環境可以讓客戶預測成本成長並據此調整定價策略，從而確保盈利。
  • 供應鏈最佳化：尋找替代採購來源並實現供應鏈多元化可以減少對高關稅地區的依賴，並提高韌性。
  • 監管：專家指導客戶應對不斷變化的法規環境，幫助客戶保持合規並避免潛在的法律挑戰。
  • 策略規劃：深入了解關稅的影響，可以就製造地、夥伴關係和打入市場策略做出明智的決策。

目錄

第1章 血管內超音波市場報告概述

2. 血管內超音波市場執行摘要

  • 市場概覽

第3章：血管內超音波市場關鍵因素分析

  • 血管內超音波市場促進因素
  • 血管內超音波市場限制與挑戰
  • 血管內超音波市場機遇

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

6. 血管內超音波市場的波特五力分析

第7章 血管內超音波市場估值

  • 按類型
    • IVUS導管
    • IVUS主機
  • 透過使用
    • 冠狀動脈介入治療
    • 周邊干預
  • 最終用戶
    • 醫院和診所
    • 診斷影像中心
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

10. 血管內超音波市場公司及產品概況

  • Koninklijke Philips NV
  • Boston Scientific Corporation
  • Terumo Corporation
  • NIPRO
  • CONAVI MEDICAL
  • Bracco
  • Intravascular Imaging Incorporated (i3)
  • Insight Lifetech Co., Ltd.
  • Shanghai Pulse Medical Technology Inc.
  • MicroPort Scientific Corporation
  • Provisio Medical, Inc.

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0441

Intravascular Ultrasound Market Summary

  • The global intravascular ultrasound market is expected to increase from USD 926.94 million in 2025 to USD 1,774.19 million by 2034, reflecting strong and sustained growth.
  • The global intravascular ultrasound market is growing at a CAGR of 7.52% during the forecast period from 2026 to 2034.
  • The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.
  • The leading companies operating in the intravascular ultrasound market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, NIPRO, CONAVI MEDICAL, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., MicroPort Scientific Corporation, Provisio Medical, Inc., and others.
  • North America is expected to dominate the overall intravascular ultrasound market due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.
  • In the type segment of the intravascular ultrasound market, the IVUS catheters category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Intravascular Ultrasound Market

  • Rising prevalence of cardiovascular diseases and associated risk factors leading to a surge in intravascular ultrasound: The rising prevalence of cardiovascular diseases (CVDs) and associated risk factors such as hypertension, diabetes, obesity, and an aging population is significantly boosting the overall market for Intravascular Ultrasound (IVUS) systems.
  • The expanding use of IVUS due to the surge in percutaneous coronary interventions (PCI) esclating the market of intravascular ultrasound: The expanding use of Intravascular Ultrasound (IVUS) due to the surge in percutaneous coronary interventions (PCI) is significantly driving the growth of the IVUS market. PCI procedures, such as angioplasty and stent placement, have become the preferred treatment option for coronary artery disease (CAD) due to their minimally invasive nature, reduced recovery time, and lower procedural risks compared to traditional coronary artery bypass grafting (CABG).
  • Surging strategic activities such as acquisitions, partnerships, R&D, and others by key market players: The growing product development activities across the globe are a cornerstone of the booming intravascular ultrasound market. Advances in technology, expanding disease applications, approvals, and strategic collaborations are enabling the creation of innovative diagnostic solutions. With continued investment and innovation, intravascular ultrasound are set to transform healthcare by offering non-invasive, accurate, and personalized diagnostic tools for a wide range of diseases.

Intravascular Ultrasound Market Report Segmentation

This intravascular ultrasound market report offers a comprehensive overview of the global Intravascular Ultrasound market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Type (IVUS Catheters and IVUS Consoles), Application (Coronary Interventions and Peripheral Interventions), End-Users (Hospitals and Clinics, Diagnostic Imaging Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing intravascular ultrasound market.

Intravascular ultrasound (IVUS), a catheter-based invasive imaging modality has applications in interventional cardiology for the characterization of lesion morphology, quantification of plaque burden, stent size guidance, assessment of stent expansion, and in identification of procedural complications.

The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.

What are the latest intravascular ultrasound market dynamics and trends?

The global market for intravascular ultrasound has witnessed significant growth in recent years, largely driven by the rising prevalence of cardiovascular diseases (CVDs) and associated risk factors, the expanding use of Intravascular Ultrasound (IVUS) due to the surge in percutaneous coronary interventions (PCI), and increase in product development activities among the key market players.

According to the World Heart Federation (2024), approximately 60 million population was affected by atrial fibrillation which is one of the most common types of irregular heartbeat, or arrhythmia. It can increase the risk of blood clots, heart failure and stroke. Additionally, as per the same source people with atrial fibrillation were 5X times more likely to suffer a stroke.

Atrial fibrillation, the most common cardiac arrhythmia, is associated with a heightened risk of thromboembolic events, stroke, and structural heart complications. As AF management increasingly involves catheter-based interventions such as pulmonary vein isolation (PVI), left atrial appendage (LAA) closure, and atrial fibrillation ablation, IVUS plays a critical role in guiding these procedures by providing real-time, high-resolution imaging of vascular structures and thereby boosting the overall IUVS market.

According to a recent data provided by British Heart Foundation (2024), globally, around 56 million women and 45 million men were stroke survivors. It's estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed. Congenital heart disease patients who undergo surgical corrections often need long-term monitoring and intervention, where IVUS serves as a minimally invasive diagnostic tool to assess graft patency, evaluate vascular remodeling, and detect post-surgical complications.

Additionally, according to the data provided by the University of Michigan (2024), more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally invasive procedure to unclog the arteries that feed the heart.

As PCI becomes the primary treatment for CAD, interventional cardiologists increasingly rely on IVUS for enhanced procedural outcomes. Unlike traditional angiography, IVUS provides real-time, high-resolution cross-sectional imaging, enabling precise vessel assessment, plaque analysis, and optimal stent placement. This has driven higher IVUS adoption, improving PCI success rates and reducing complications, thereby boosting its market demand.

Thus, the growth of IUVS is closely linked to the annual volume of PCI procedures and the increasing integration of IVUS in both pre-stenting and post-stenting applications. For example, Boston Scientific offers the OPTICROSS(TM) HD Coronary Imaging Catheters, which provide high-definition imaging to assist in accurate stent placement and assessment of procedural results. Additionally, their AVVIGO(TM)+ Multi-Modality Guidance System integrates IVUS and Fractional Flow Reserve (FFR) capabilities, enhancing vessel imaging and physiological assessments during PCI.

Furthermore, the increase in product development activites are further boosting the overall market of IVUS. For instance, in March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System.

Thus, the factors mentioned above are expected to boost the overall market of intravascular ultrasound during the forecast period from 202 to 2034.

However, IVUS catheter can sometimes cause mechanical trauma to the arterial wall during insertion, manipulation, or withdrawal lading to vessel dissection and presence of alternatives such as optical coherence tomography (OCT) and advanced angiography may limit the future market of IVUS during the forecast period.

Intravascular Ultrasound Market Segment Analysis

Intravascular Ultrasound Market by Type (IVUS Catheters and IVUS Consoles), Application (Coronary Interventions and Peripheral Interventions), End-Users (Hospitals and Clinics, Diagnostic Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Intravascular Ultrasound Market Regional Analysis

North America Intravascular Ultrasound Market Trends

North America is expected to account for the highest proportion of 43.72% of the Intravascular Ultrasound market in 2025, out of all regions. This domination is due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.

According to the recent data provided by Centre for Disease Control and Prevention (2024), in 2022, approximately 4.8% of adults have been diagnosed with coronary heart disease. Patients with CHD develop atherosclerosis, leading to restricted blood flow and a higher risk of heart attacks. As CHD cases rise, the demand for advanced imaging technologies like IVUS increases for diagnosis, thereby driving market growth.

Moreover, according to the data provided by the Centre for Disease Control and Prevention (2024), the prevalence of obesity among adults was 40.3% during 2021 to 2023. Excess weight leads to metabolic disorders, accelerating plaque buildup and increasing the need for PCI. Thus, IVUS plays a key role in guiding stent placement and optimizing treatment, thereby driving its market growth.

Additionally, according to the data provided by the University of Michigan (2025), angioplasty is done on more than a million people a year in the United States. During angioplasty, IVUS helps in accurate assess of plaque and lesion characteristics, guide stent placement and expansion as a result, IVUS adoption is expected to escalate in the region.

Thus, all the above-mentioned factors are anticipated to propel the market for intravascular ultrasound in the United States during the forecast period.

Europe Intravascular Ultrasound Market Trends

In Europe, the growth of the intravascular ultrasound market is being strongly driven by the rising prevalence of cardiovascular disorders, risk factors such as diabetes, obesity, and high blood pressure across the region thereby boosting the overall market of IVUS market.

According to the data provided by the British Heart Foundation (2024), 7.6 million people are living with heart and circulatory disease. The rising incidence of conditions like atherosclerosis, heart attacks, and strokes is driving the demand for advanced diagnostic tools such as intravascular ultrasound (IVUS), as it provides real-time imaging of coronary arteries and helps in the assessment of plaque buildup, vessel diameter, and stent placement.

Additionally, according to the data provided by the Diabetes UK Organization (2024), in 2023-2024, approximately 5.8 million people in the UK were living with diabetes.

Furthermore, according to the data provided by the Government of UK (2024), 63.8% of adults aged 18 and over were overweight or living with obesity in the United Kingdom.

Moreover, the stats provided by the British Heart Foundation (2025), five million adults in the UK had undiagnosed high blood pressure. Thus, the rising prevalence of risk factors such as diabetes, obesity, and hypertension increases the adoption rate of IVUS-guided interventions to improve procedural outcomes, reduce post-surgical complications, and enhance long-term patient survival rates.

Hence, all the factors mentioned above are expected to drive the market for intravascular ultrasound in the United Kingdom during the forecast period.

Asia-Pacific Intravascular Ultrasound Market Trends

The Asia Pacific region is projectd to grow at a healthy CAGR of 8.86% during the forecast period from 2026 to 2034 and is emerging as a significant growth driver for the intravascular ultrasound market, fueled by rising growing geriatric population and the increasing prevalence of cardiological disorders and associated risk factors.

As per the recent study published in the Journal of National Library of Medicine 2024, it was estimated that approximately 330 million individuals in China are affected by CVD on average.

Among them, there are 13 million cases of stroke, 11.4 million cases of coronary heart disease, 5 million cases of pulmonary heart disease, 8.9 million cases of heart failure, 4.9 million cases of atrial fibrillation, 2.5 million cases of rheumatic heart disease, 2 million cases of congenital heart disease, 45.3 million cases of lower extremity artery disease, and 245 million cases of hypertension.

Additionally, according to the IDF Diabetes Atlas (2024), in 2045, the age-adjusted comparative prevalence of diabetes would increase to 12.6% in China.

As these conditions often involve complex arterial blockages and atherosclerosis, IVUS plays a crucial role in providing high-resolution, real-time imaging of blood vessels, allowing cardiologists to assess plaque burden, vessel size, and lesion characteristics with precision. This enhances the accuracy of percutaneous coronary interventions (PCI) by optimizing stent placement and reducing complications like restenosis and stent thrombosis and thereby boosting the overall market of IUVS.

Who are the major players in the intravascular ultrasound market?

The following are the leading companies in the intravascular ultrasound market. These companies collectively hold the largest market share and dictate industry trends.

  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Terumo Corporation
  • NIPRO
  • CONAVI MEDICAL
  • Bracco
  • Intravascular Imaging Incorporated (i3)
  • Insight Lifetech Co., Ltd.
  • Shanghai Pulse Medical Technology Inc.
  • MicroPort Scientific Corporation
  • Provisio Medical, Inc.
  • Others

How is the competitive landscape shaping the intravascular ultrasound market?

The intravascular ultrasound (IVUS) market is characterized by a moderately to highly concentrated competitive landscape, dominated by a small group of global medtech leaders most notably Boston Scientific, Philips Healthcare, Terumo, and Medtronic which together account for over half of the total market share, driven by their strong cath-lab presence, broad imaging portfolios, and long-standing clinician trust. These players shape competition through continuous product innovation, AI-enabled imaging enhancements, integration with interventional platforms, and strategic acquisitions, reinforcing high entry barriers for new entrants. At the same time, smaller and niche companies compete by focusing on differentiated catheter technologies, hybrid imaging, or cost-effective solutions tailored to specific regions, particularly in emerging markets. As a result, while large incumbents maintain pricing power and scale advantages, ongoing technological advancements and clinical demand for precision-guided interventions ensure the market remains competitive rather than fully consolidated.

Recent Developmental Activities in the Intravascular Ultrasound Market

  • In March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System.
  • In October 2024, MicroPort(R) MicroImaging, a subsidiary of MicroPort Scientific Corporation, obtained approval from the National Medical Products Administration (NMPA) for the marketing of its Decypher(TM) IVUS Diagnostic System and Outsight(R) Disposable IVUS Diagnostic Catheter.
  • In May 2024, Provisio Medical, Inc., announced the completion of the first commercial clinical cases utilizing the Provisio(TM) SLT IVUS(TM) System.
  • In April 2024, Provisio Medical's Provisio(TM) SLT IVUS(TM) System received FDA 510(k) clearance, introducing Sonic Lumen Tomography (SLT) technology for real-time, automatic blood vessel lumen measurement without complex image interpretation. It is the first integrated intravascular imaging and support crossing catheter, enabling simultaneous lumen measurement, visualization, guidewire support, and contrast agent delivery, enhancing vascular procedures.
  • In October 2023, Evident Vascular exits stealth with US$35 million Series A funding to develop intravascular imaging platform.

Intravascular Ultrasound Market Segmentation

  • Intravascular Ultrasound by Type Exposure
  • IVUS Catheters
  • IVUS Consoles
  • Intravascular Ultrasound Application Exposure
  • Coronary Interventions
  • Peripheral Interventions
  • Intravascular Ultrasound End-Users Exposure
  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Others
  • Intravascular Ultrasound Geography Exposure
  • North America Intravascular Ultrasound Market
  • United States Intravascular Ultrasound Market
  • Canada Intravascular Ultrasound Market
  • Mexico Intravascular Ultrasound Market
  • Europe Intravascular Ultrasound Market
  • United Kingdom Intravascular Ultrasound Market
  • Germany Intravascular Ultrasound Market
  • France Intravascular Ultrasound Market
  • Italy Intravascular Ultrasound Market
  • Spain Intravascular Ultrasound Market
  • Rest of Europe Intravascular Ultrasound Market
  • Asia-Pacific Intravascular Ultrasound Market
  • China Intravascular Ultrasound Market
  • Japan Intravascular Ultrasound Market
  • India Intravascular Ultrasound Market
  • Australia Intravascular Ultrasound Market
  • South Korea Intravascular Ultrasound Market
  • Rest of Asia-Pacific Intravascular Ultrasound Market
  • Rest of the World Intravascular Ultrasound Market
  • South America Intravascular Ultrasound Market
  • Middle East Intravascular Ultrasound Market
  • Africa Intravascular Ultrasound Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-Powered Innovations and Applications in IVUS are rapidly transforming how intravascular ultrasound is performed and interpreted, moving the technology beyond manual image review toward automated, data-driven clinical decision support. Modern AI algorithms especially deep learning models are being developed to automatically segment lumen, vessel walls, plaque, and stent structures with high accuracy, significantly reducing the need for manual annotation and inter-operator variability during IVUS interpretation. These models can classify vessel components (e.g., calcification or narrow lumina), quantify key anatomical metrics, and assist in lesion characterization, which can improve diagnostic consistency and support treatment planning. AI is also being used to predict procedural outcomes (such as regions affected by rotational atherectomy) and may be extended to broader risk prediction models for adverse cardiovascular events by integrating IVUS imaging with clinical and demographic data. Beyond direct clinical interpretation, AI is accelerating clinician training and proficiency-for example, adaptive educational platforms powered by AI provide personalized, case-based IVUS learning pathways that build pattern recognition and decision-making skills more efficiently. Together, these innovations aim to enhance workflow efficiency, standardize image analysis, and expand the utility and adoption of IVUS in cardiovascular interventions

U.S. Tariff Impact Analysis on Intravascular Ultrasound Market:

The U.S. tariff impact on the Intravascular Ultrasound (IVUS) market reflects broader strains on the U.S. medical device sector caused by recent tariff policies aimed at reshoring manufacturing and reducing dependence on foreign supply chains. Under new trade measures, tariffs of up to double-digit percentages on imported medical devices and components including diagnostic and imaging equipment have been implemented, significantly increasing manufacturing and procurement costs for devices or parts sourced from China, the EU, and other regions, which are crucial suppliers for advanced cardiovascular technologies like IVUS. These heightened duties place margin pressure on both U.S. and foreign IVUS manufacturers, who may face cost-pass-through to hospitals and healthcare providers or absorb higher input costs, potentially slowing adoption in cost-sensitive environments and delaying upgrades of imaging technologies. Supply chain disruptions caused by tariffs make long-established global production networks less efficient, spurring some firms to consider reshoring or diversifying supply bases, but such shifts are costly and time-intensive due to regulatory approvals and manufacturing retooling. Ultimately, tariff-driven cost increases and uncertainty could constrain growth in the U.S. IVUS market by elevating prices, creating procurement challenges for healthcare providers, and dampening demand for cutting-edge imaging modalities unless mitigated by policy adjustments or tariff exemptions for critical medical technologies.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the intravascular ultrasound market report study

  • Market size analysis for the current intravascular ultrasound market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the intravascular ultrasound market.
  • Various opportunities available for the other competitors in the intravascular ultrasound market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current intravascular ultrasound market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the intravascular ultrasound market growth in the future?

Frequently Asked Questions for the Intravascular Ultrasound Market

1. What is the growth rate of the intravascular ultrasound market?

  • The intravascular ultrasound market is estimated to grow at a CAGR of 7.52% during the forecast period from 2026 to 2034.

2. What is the market for intravascular ultrasound?

  • The global intravascular ultrasound market is expected to increase from USD 926.94 million in 2025 to USD 1,774.19 million by 2034.

3. Which region has the highest share in the intravascular ultrasound market?

  • North America is expected to dominate the overall intravascular ultrasound market due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.

4. What are the drivers for the intravascular ultrasound market?

  • The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.

5. Who are the key players operating in the intravascular ultrasound market?

  • Some of the key market players operating in the intravascular ultrasound market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, NIPRO, CONAVI MEDICAL, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., MicroPort Scientific Corporation, Provisio Medical, Inc., and others.

Table of Contents

1. Intravascular Ultrasound Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Intravascular Ultrasound Market Executive Summary

  • 2.1 Market at Glance

3. Intravascular Ultrasound Market Key Factors Analysis

  • 3.1 Intravascular Ultrasound Market Drivers
    • 3.1.1 Rising prevalence of cardiovascular diseases and associated risk factors
    • 3.1.2 The expanding use of IVUS due to the surge in percutaneous coronary interventions (PCI)
    • 3.1.3 Surging strategic activities such as acquisitions, partnerships, R&D, and others by key market players
  • 3.2 Intravascular Ultrasound Market Restraints and Challenges
    • 3.2.1 Presence of alternatives such as optical coherence tomography (OCT) and advanced angiography
    • 3.2.2 Risk of catheter-related complications
  • 3.3 Intravascular Ultrasound Market Opportunity
    • 3.3.1 Expanding advancements in IVUS such as high-resolution imaging, 3D IVUS, AI analysis, and plaque quantification

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Intravascular Ultrasound Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Intravascular Ultrasound Market Assessment

  • 7.1 By Type
    • 7.1.1 IVUS Catheters
    • 7.1.2 IVUS Consoles
  • 7.2 By Application
    • 7.2.1 Coronary Interventions
    • 7.2.2 Peripheral Interventions
  • 7.3 By End-Users
    • 7.3.1 Hospitals and Clinics
    • 7.3.2 Diagnostic Imaging Centers
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Intravascular Ultrasound Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Intravascular Ultrasound Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.3 India Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Intravascular Ultrasound Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Intravascular Ultrasound Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Intravascular Ultrasound Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Boston Scientific Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Terumo Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 NIPRO
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 CONAVI MEDICAL
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Bracco
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Intravascular Imaging Incorporated (i3)
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Insight Lifetech Co., Ltd.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Shanghai Pulse Medical Technology Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 MicroPort Scientific Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Provisio Medical, Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Intravascular Ultrasound Market in Global (2023-2034)
  • Table 2: Intravascular Ultrasound Market in Global by Type (2023-2034)
  • Table 3: Intravascular Ultrasound Market in Global by Application (2023-2034)
  • Table 4: Intravascular Ultrasound Market in Global by End-Users (2023-2034)
  • Table 5: Intravascular Ultrasound Market in Global by Geography (2023-2034)
  • Table 6: Intravascular Ultrasound Market in North America (2023-2034)
  • Table 7: Intravascular Ultrasound Market in the United States (2023-2034)
  • Table 8: Intravascular Ultrasound Market in Canada (2023-2034)
  • Table 9: Intravascular Ultrasound Market in Mexico (2023-2034)
  • Table 10: Intravascular Ultrasound Market in Europe (2023-2034)
  • Table 11: Intravascular Ultrasound Market in France (2023-2034)
  • Table 12: Intravascular Ultrasound Market in Germany (2023-2034)
  • Table 13: Intravascular Ultrasound Market in United Kingdom (2023-2034)
  • Table 14: Intravascular Ultrasound Market in Italy (2023-2034)
  • Table 15: Intravascular Ultrasound Market in Spain (2023-2034)
  • Table 16: Intravascular Ultrasound Market in the Rest of Europe (2023-2034)
  • Table 17: Intravascular Ultrasound Market in Asia-Pacific (2023-2034)
  • Table 18: Intravascular Ultrasound Market in China (2023-2034)
  • Table 19: Intravascular Ultrasound Market in Japan (2023-2034)
  • Table 20: Intravascular Ultrasound Market in India (2023-2034)
  • Table 21: Intravascular Ultrasound Market in Australia (2023-2034)
  • Table 22: Intravascular Ultrasound Market in South Korea (2023-2034)
  • Table 23: Intravascular Ultrasound Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Intravascular Ultrasound Market in the Rest of the World (2023-2034)
  • Table 25: Intravascular Ultrasound Market in the Middle East (2023-2034)
  • Table 26: Intravascular Ultrasound Market in Africa (2023-2034)
  • Table 27: Intravascular Ultrasound Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Intravascular Ultrasound Market Drivers
  • Figure 2: Intravascular Ultrasound Market Restraints
  • Figure 3: Intravascular Ultrasound Market Opportunities
  • Figure 4: AI-Powered Innovations in Intravascular Ultrasound Market
  • Figure 5: US Tariff Impact on Intravascular Ultrasound Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Intravascular Ultrasound Market in Global (2023-2034)
  • Figure 10: Intravascular Ultrasound Market in Global by Component (2023-2034)
  • Figure 11: Intravascular Ultrasound Market in Global by Application (2023-2034)
  • Figure 12: Intravascular Ultrasound Market in Global by End-Users (2023-2034)
  • Figure 13: Intravascular Ultrasound Market in Global by Geography (2023-2034)
  • Figure 14: Intravascular Ultrasound Market in North America (2023-2034)
  • Figure 15: Intravascular Ultrasound Market in the United States (2023-2034)
  • Figure 16: Intravascular Ultrasound Market in Canada (2023-2034)
  • Figure 17: Intravascular Ultrasound Market in Mexico (2023-2034)
  • Figure 18: Intravascular Ultrasound Market in Europe (2023-2034)
  • Figure 19: Intravascular Ultrasound Market in France (2023-2034)
  • Figure 20: Intravascular Ultrasound Market in Germany (2023-2034)
  • Figure 21: Intravascular Ultrasound Market in United Kingdom (2023-2034)
  • Figure 22: Intravascular Ultrasound Market in Italy (2023-2034)
  • Figure 23: Intravascular Ultrasound Market in Spain (2023-2034)
  • Figure 24: Intravascular Ultrasound Market in the Rest of Europe (2023-2034)
  • Figure 25: Intravascular Ultrasound Market in Asia-Pacific (2023-2034)
  • Figure 26: Intravascular Ultrasound Market in China (2023-2034)
  • Figure 27: Intravascular Ultrasound Market in Japan (2023-2034)
  • Figure 28: Intravascular Ultrasound Market in India (2023-2034)
  • Figure 29: Intravascular Ultrasound Market in Australia (2023-2034)
  • Figure 30: Intravascular Ultrasound Market in South Korea (2023-2034)
  • Figure 31: Intravascular Ultrasound Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Intravascular Ultrasound Market in the Rest of the World (2023-2034)
  • Figure 33: Intravascular Ultrasound Market in the Middle East (2023-2034)
  • Figure 34: Intravascular Ultrasound Market in Africa (2023-2034)
  • Figure 35: Intravascular Ultrasound Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding & Investment Trends